Format

Send to

Choose Destination
Clin Case Rep. 2016 Jun 9;4(7):687-91. doi: 10.1002/ccr3.596. eCollection 2016 Jul.

A transient increase and subsequent sharp decrease of chemo-refractory liver-metastasized uterine cervical small cell carcinoma to autologous formalin-fixed tumor vaccine plus anti-PD-1 antibody.

Author information

1
Ginza-Namiki-Dori Clinic Ginza 4-2-2 First Yayoi Bldg 7F Chuo-ku Tokyo 104-0061 Japan.
2
Cell-Medicine, Inc. Sengen 2-1-6 Tsukuba Science City Ibaraki 305-0047 Japan.

Abstract

Uterine cervical small cell carcinoma is rare and aggressive with no standardized therapy. A patient bearing the advanced chemo-refractory carcinoma, treated with a tumor vaccine combined with 1 mg/kg of pembrolizumab, showed a transient increase and subsequent sharp decrease of the liver-metastasized lesion to less than half its maximum diameter.

KEYWORDS:

Anti‐PD‐1 antibody; cancer vaccine; radiation therapy; uterine cervical small cell carcinoma

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center